Leverage Shares 2X Long AAL Daily ETF
AALG
3 hedge funds and large institutions have $315K invested in Leverage Shares 2X Long AAL Daily ETF in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
18% more capital invested
Capital invested by funds: $266K → $315K (+$49K)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
7.11% less ownership
Funds ownership: 16.69% → 9.59% (-7.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$179K |
| 2 |
VF
Virtu Financial
New York
|
+$141K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$3.22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$514 |
AALG Hedge Fund Activity: Q1 2026 in Review
3 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Leverage Shares 2X Long AAL Daily ETF (AALG) for Q1 2026, worth a combined $315K — up 18% from $266K a quarter earlier.
Fund positioning in AALG was balanced in Q1 2026: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $179K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $514 sold.
- 3 institutional investors held Leverage Shares 2X Long AAL Daily ETF (AALG) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $315K of Leverage Shares 2X Long AAL Daily ETF stock for Q1 2026, up 18% quarter-over-quarter.
- 1 fund opened new Leverage Shares 2X Long AAL Daily ETF positions in Q1 2026 and 1 closed out, a net change of 0 holders.
- The largest Leverage Shares 2X Long AAL Daily ETF buyer in Q1 2026 was Jane Street, an estimated $179K added.
- The largest Leverage Shares 2X Long AAL Daily ETF seller in Q1 2026 was Tower Research Capital (TRC), an estimated $514 sold.
Based on aggregated 13F filings for Q1 2026.